Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Protective levels of vitamin D achievable in SCD with oral supplementation

Publish date:: May 12, 2020

Key clinical point: Oral vitamin D3 supplementation can achieve protective levels in children with sickle cell disease.

Major finding: A daily 800 IU dose of vitamin D3 was a protective factor (P = .044) to reach optimal blood levels (≥ 30ng/mL).

Study details: Prospective, single-center study of 80 children with SCD.

Disclosures: The authors reported that they had no conflicts of interest.

Citation:

Garrido C et al. Bone. 2020;133: doi.org/10.1016/j.bone.2020.115228.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Bleeding Disorders

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

Hemochromatosis variants may confer 10-fold higher risk of liver cancer,

Hemophilia, von Willebrand disease do not increase postop complications for ACL reconstruction,

Mouth splints decrease risk of post–dental extraction bleeding in hemophilia,

Low VWF levels or blood group O not linked to intracerebral hemorrhage risk,

All Specialties